Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-15

FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

The FDA approved a supplemental application for MS CONTIN (morphine sulfate) from Rhodes Pharmaceuticals L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MS CONTIN (Morphine sulfate)

Snippet

SUPPL AP for MS CONTIN (MORPHINE SULFATE)